We are live on
!
Find out more
Los Angeles Capital Management Portfolio holdings
AUM
$25.4B
1-Year Est. Return
38.46%
This Fund
S&P 500
This Quarter
Est. Return
+13.32%
1 Year Est. Return
+38.46%
3 Year Est. Return
+154.38%
5 Year Est. Return
+223.79%
10 Year Est. Return
+923.25%
AUM
$29.5B
AUM Growth
+$2.76B
(+10%)
Cap. Flow
+$238M
Cap. Flow
% of AUM
0.81%
Top 10 Holdings %
Top 10 Hldgs %
40.87%
Holding
1,571
New
251
Increased
436
Reduced
548
Closed
227
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVIDIA
NVDA
|
+$251M |
| 2 |
Apple
AAPL
|
+$168M |
| 3 |
Advanced Micro Devices
AMD
|
+$152M |
| 4 |
Gilead Sciences
GILD
|
+$139M |
| 5 |
Palantir
PLTR
|
+$137M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Visa
V
|
+$362M |
| 2 |
Tesla
TSLA
|
+$233M |
| 3 |
Costco
COST
|
+$192M |
| 4 |
Walmart Inc
WMT
|
+$167M |
| 5 |
Mastercard
MA
|
+$161M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 37.6% |
| 2 | Communication Services | 12.78% |
| 3 | Healthcare | 12.39% |
| 4 | Financials | 10.47% |
| 5 | Industrials | 9.55% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1301
Bumble
BMBL
$344M
| $154K | ﹤0.01% |
+25,275
| New | +$173K |
|
1302
InnovAge Holding
INNV
$1.42B
| $154K | ﹤0.01% |
29,750
| – | – |
|
1303
Talkspace
TALK
$869M
| $147K | ﹤0.01% |
53,395
-1,690
| -3% | -$4.38K |
|
1304
3D Systems Corp
DDD
$603M
| $147K | ﹤0.01% |
+50,595
| New | +$104K |
|
1305
Xeris Biopharma Holdings
XERS
$1.55B
| $146K | ﹤0.01% |
17,901
-2,481
| -12% | -$16.5K |
|
1306
Tango Therapeutics
TNGX
$4.31B
| $144K | ﹤0.01% |
17,185
+6,895
| +67% | +$46.7K |
|
1307
Coherus Oncology
CHRS
$181M
| $144K | ﹤0.01% |
87,945
-299,971
| -77% | -$334K |
|
|
AIOT
1308
PowerFleet Inc
AIOT
$421M
| $144K | ﹤0.01% |
27,500
| – | – |
|
1309
Arvinas
ARVN
$580M
| $143K | ﹤0.01% |
16,824
-22,977
| -58% | -$174K |
|
1310
Community Health Systems
CYH
$410M
| $131K | ﹤0.01% |
40,938
-79,479
| -66% | -$239K |
|
|
ESPR
1311
DELISTED
Esperion Therapeutics
ESPR
| $128K | ﹤0.01% |
48,172
| – | – |
|
1312
Core Laboratories
CLB
$571M
| $126K | ﹤0.01% |
+10,186
| New | +$119K |
|
1313
Digimarc Corp
DMRC
$167M
| $120K | ﹤0.01% |
+12,284
| New | +$132K |
|
1314
Fate Therapeutics
FATE
$317M
| $120K | ﹤0.01% |
+95,185
| New | +$103K |
|
1315
SunCoke Energy
SXC
$801M
| $115K | ﹤0.01% |
14,126
-21,304
| -60% | -$170K |
|
1316
Arteris
AIP
$1.39B
| $112K | ﹤0.01% |
+11,050
| New | +$105K |
|
|
KW
1317
DELISTED
Kennedy-Wilson Holdings
KW
| $110K | ﹤0.01% |
+13,225
| New | +$106K |
|
1318
Krispy Kreme
DNUT
$573M
| $105K | ﹤0.01% |
27,135
-424
| -2% | -$1.46K |
|
1319
MaxCyte
MXCT
$136M
| $100K | ﹤0.01% |
63,330
| – | – |
|
1320
Western Union
WU
$2.23B
| $99.9K | ﹤0.01% |
12,505
-6,345
| -34% | -$53.1K |
|
1321
4D Molecular Therapeutics
FDMT
$621M
| $98K | ﹤0.01% |
11,280
| – | – |
|
1322
Global Net Lease
GNL
$1.9B
| $87.5K | ﹤0.01% |
+10,759
| New | +$82.1K |
|
1323
Sana Biotechnology
SANA
$1.13B
| $82.4K | ﹤0.01% |
23,210
-45
| -0.2% | -$163 |
|
1324
Akebia Therapeutics
AKBA
$248M
| $80.8K | ﹤0.01% |
29,607
+2,864
| +11% | +$9.53K |
|
|
SNBR
1325
DELISTED
Sleep Number
SNBR
| $78.5K | ﹤0.01% |
+11,180
| New | +$97.9K |
|
Similar funds
VAI
Los Angeles Capital Management's Q3 2025 Portfolio in Review
As of Q3 2025, Los Angeles Capital Management held 1,571 positions worth $29.5B, up 10% from $26.7B the previous quarter. Its ten largest holdings account for 41% of the portfolio.
Los Angeles Capital Management's Q3 2025 filing shows 251 new, 436 increased, 548 reduced and 227 closed positions. Its largest new stake was eBay: 1,249,162 shares worth $114M. The largest sale was Visa, an estimated $362M.
By sector, the portfolio is most concentrated in Technology at 38% of assets, up from 34% a quarter earlier, followed by Communication Services and Healthcare.
- Los Angeles Capital Management's largest Q3 2025 buy was eBay: 1,249,162 shares worth $114M.
- Los Angeles Capital Management added most to NVIDIA in Q3 2025, an estimated $251M increase.
- Los Angeles Capital Management's biggest Q3 2025 reduction was Visa, cutting an estimated $362M.
- Los Angeles Capital Management fully exited VeriSign in Q3 2025, selling an estimated $20.2M.
- Los Angeles Capital Management's ten largest holdings make up 41% of its $29.5B portfolio in Q3 2025.
- Los Angeles Capital Management opened 251 new positions and closed 227 in Q3 2025.
- Los Angeles Capital Management's portfolio value rose 10% quarter-over-quarter to $29.5B.
Based on Los Angeles Capital Management's 13F filing for Q3 2025, filed 20 Oct 2025.